Loading institutional data...
Loading institutional data...
Held by 738 of 2,417 reporting institutions (99th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 8%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $4.01B covers the $1.00B due within a year 4.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~3.8% on $15.86B of debt.
Cash of $4.01B fully covers short-term debt of $1.00B.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 30% of free cash flow, leaving room to grow it and fund buybacks. Last year: $1.28B dividends + $0 buybacks = $1.28B returned on $4.28B FCF.
9 consecutive years of dividend increases · 9%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
Ranked against 16 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYK | $111.9B | 34.8× | 19.2× | 4.5× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 1.8× | 738 |
| MMM | $89.9B | 29.1× | 17.3× | 3.6× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 788 |
| BSX | $60.8B | 21.6× | 11.9× | 3.0× | 19.9% | 69.0% | 14.4% | 11.9% | 11.8% | -0.3× | 407 |
| BDX | $53.9B | 34.0× | 14.4× | 2.5× | 8.2% | 45.4% | 7.7% | 6.6% | 3.8% | 3.7× | 458 |
| RMD | $32.3B | 22.1× | 15.1× | 5.7× | 9.9% | 61.1% | 26.9% | 23.1% | 21.0% | -0.4× | — |
| DXCM | $31.1B | 39.4× | 25.9× | 6.7× | 15.6% | 60.1% | 17.9% | 30.5% | 30.5% | -0.8× | 287 |
| WST | $28.8B | 60.8× | 37.3× | 9.4× | 6.3% | 35.9% | 16.1% | 15.5% | 14.6% | -0.8× | 237 |
| MDLN | $28.2B | — | 12.0× | 1.0× | — | 26.4% | 4.1% | 10.8% | 5.0% | 3.3× | 84 |
| GKOS | $14.1B | — | — | 27.7× | 32.3% | 55.7% | -37.0% | -28.6% | -28.6% | — | 82 |
| SOLV | $13.8B | 9.2× | 6.7× | 1.7× | 0.9% | 53.5% | 18.7% | 30.8% | 15.4% | 1.6× | 246 |
| PEN | $12.6B | 70.6× | 59.9× | 8.9× | 17.5% | 67.1% | 12.7% | 12.4% | 12.4% | -0.9× | 76 |
| BAX | $11.9B | — | 28.8× | 1.1× | 5.7% | 30.1% | -8.5% | -15.6% | -6.1% | 11.1× | 197 |
| GMED | $10.5B | 19.9× | 13.2× | 3.6× | 16.7% | 67.4% | 18.3% | 11.8% | 11.8% | -0.7× | 146 |
| PODD | $10.4B | 43.0× | 18.4× | 3.8× | 30.7% | 71.6% | 9.1% | 16.3% | 16.1% | 0.0× | 164 |
| TFX | $5.9B | — | 46.9× | 3.0× | 17.2% | 56.2% | -45.4% | -29.0% | -15.7% | 13.0× | 73 |
| HAE | $5.4B | 58.4× | 29.5× | 4.1× | -2.0% | 59.0% | 7.3% | 12.2% | 4.8% | 4.5× | 58 |
| MMSI | $5.1B | 40.5× | 17.7× | 3.4× | 11.8% | 48.7% | 8.5% | 8.1% | 5.5% | 0.9× | 94 |
Peers = companies sharing SYK's sector (Surgical & Medical Instruments & Apparatus) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $291.86 today, the market must believe free cash flow compounds 10.1%/yr for a decade (off $3.64B on the 3-yr avg basis).
On the basis ($3.41B) the requirement is 10.9%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 10.1% is more conservative than its 9-yr track record.
Default is 8.0% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.38B shares (market data) · net debt $11.85B
mean 21.9% · volatility σ 51% · implied rate exceeded in 5/9 yrs
Central path = implied 10.1%/yr growth; shaded band = ±1σ (51%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $25.12B 100.0% | $22.59B 100.0% | $20.50B 100.0% | $18.45B 100.0% | $17.11B 100.0% | $14.35B 100.0% | $14.88B 100.0% | $13.60B 100.0% | $12.44B 100.0% | $11.32B 100.0% |
| Cost of Revenue | $9.05B 36.0% | $8.15B 36.1% | $7.44B 36.3% | $6.87B 37.2% | $6.14B 35.9% | $5.29B 36.9% | $5.19B 34.9% | $4.66B 34.3% | $4.26B 34.3% | $3.82B 33.7% |
| Cost of Products | — | — | — | — | — | — | — | — | $4.27B 34.3% | $3.83B 33.8% |
| Gross Profit | $16.07B 64.0% | $14.44B 63.9% | $13.06B 63.7% | $11.58B 62.8% | $10.97B 64.1% | $9.06B 63.1% | $9.70B 65.1% | $8.94B 65.7% | $8.18B 65.7% | $7.50B 66.3% |
| Research & Development | $1.62B 6.5% | $1.47B 6.5% | $1.39B 6.8% | $1.45B 7.9% | $1.24B 7.2% | $984.0M 6.9% | $971.0M 6.5% | $862.0M 6.3% | $787.0M 6.3% | $715.0M 6.3% |
| Selling, General & Admin | $8.65B 34.4% | $7.68B 34.0% | $7.11B 34.7% | $6.39B 34.6% | $6.43B 37.6% | $5.36B 37.4% | $5.36B 36.0% | $5.10B 37.5% | $4.55B 36.6% | $4.14B 36.5% |
| Total Operating Expenses | $11.18B 44.5% | $10.75B 47.6% | $9.17B 44.7% | $8.74B 47.4% | $8.38B 49.0% | $6.83B 47.6% | $6.98B 46.9% | $6.40B 47.1% | $5.88B 47.3% | $5.33B 47.1% |
| Operating Income | $4.89B 19.5% | $3.69B 16.3% | $3.89B 19.0% | $2.84B 15.4% | $2.58B 15.1% | $2.22B 15.5% | $2.71B 18.2% | $2.54B 18.7% | $2.30B 18.5% | $2.17B 19.2% |
| Interest Expense | $607.0M 2.4% | $409.0M 1.8% | $363.0M 1.8% | $337.0M 1.8% | $337.0M 2.0% | $315.0M 2.2% | $287.0M 1.9% | $264.0M 1.9% | $247.0M 2.0% | $228.0M 2.0% |
| Other Income (Expense), net | $232.0M 0.9% | $212.0M 0.9% | $148.0M 0.7% | -$158.0M -0.9% | -$303.0M -1.8% | -$269.0M -1.9% | -$151.0M -1.0% | -$181.0M -1.3% | -$234.0M -1.9% | -$254.0M -2.2% |
| Pretax Income | $4.51B 18.0% | $3.49B 15.5% | $3.67B 17.9% | $2.68B 14.5% | $2.28B 13.3% | $1.95B 13.6% | $2.56B 17.2% | $2.36B 17.3% | $2.06B 16.6% | $1.92B 17.0% |
| Income Tax Expense | $1.27B 5.0% | $499.0M 2.2% | $508.0M 2.5% | $325.0M 1.8% | $287.0M 1.7% | $355.0M 2.5% | $479.0M 3.2% | -$1.20B -8.8% | $1.04B 8.4% | $274.0M 2.4% |
| Net Income | $3.25B 12.9% | $2.99B 13.2% | $3.17B 15.4% | $2.36B 12.8% | $1.99B 11.7% | $1.60B 11.1% | $2.08B 14.0% | $3.55B 26.1% | $1.02B 8.2% | $1.65B 14.5% |
| Per Share | ||||||||||
| EPS (Basic) | $8.49 | $7.86 | $8.34 | $6.23 | $5.29 | $4.26 | $5.57 | $9.50 | $2.73 | $4.40 |
| EPS (Diluted) | $8.40 | $7.76 | $8.25 | $6.17 | $5.21 | $4.20 | $5.48 | $9.34 | $2.68 | $4.35 |
| Weighted Avg Shares (Basic) | 382.2M | 381.0M | 379.6M | 378.2M | 377.0M | 375.5M | 374.0M | 374.1M | 374.0M | 374.1M |
| Weighted Avg Shares (Diluted) | 386.5M | 385.6M | 383.7M | 382.2M | 382.3M | 380.3M | 379.9M | 380.3M | 380.1M | 378.5M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-10-30
Where each multiple sits in its own 14-yr range · 45th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 14% against ROIC 8% — 6% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 34.3 | 34.9 | 36.9 | 35.9 | 37.2 | 36.3 | 36.1 | 36.0 |
| Gross Profit | 65.7 | 65.1 | 63.1 | 64.1 | 62.8 | 63.7 | 63.9 | 64.0 |
| R&D | 6.3 | 6.5 | 6.9 | 7.2 | 7.9 | 6.8 | 6.5 | 6.5 |
| SG&A | 37.5 | 36.0 | 37.4 | 37.6 | 34.6 | 34.7 | 34.0 | 34.4 |
| Operating Income | 18.7 | 18.2 | 15.5 | 15.1 | 15.4 | 19.0 | 16.3 | 19.5 |
| Income Tax | -8.8 | 3.2 | 2.5 | 1.7 | 1.8 | 2.5 | 2.2 | 5.0 |
| Net Income | 26.1 | 14.0 | 11.1 | 11.7 | 12.8 | 15.4 | 13.2 | 12.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on SYK: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Earns 3.07pts above its cost of capital, without much margin of safety.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 10.9% | 8.0% (today's — no rate published for this year) | 2.9pts |
| FY2020 | 7.3% | 8.0% (today's — no rate published for this year) | -0.7pts |
| FY2021 | 8.3% | 6.9% | 1.4pts |
| FY2022 | 8.1% | 8.6% | -0.6pts |
| FY2023 | 10.7% | 8.3% | 2.4pts |
| FY2024 | 9.5% | 8.2% | 1.3pts |
| FY2025 | 11.3% | 7.6% | 3.7pts |
| Now | 8.5% | 8.0% | 0.5pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 66.3% | 19.2% | 14.5% |
| FY2017 | 65.7% | 18.5% | 8.2% |
| FY2018 | 65.7% | 18.7% | 26.1% |
| FY2019 | 65.1% | 18.2% | 14.0% |
| FY2020 | 63.1% | 15.5% | 11.1% |
| FY2021 | 64.1% | 15.1% | 11.7% |
| FY2022 | 62.8% | 15.4% | 12.8% |
| FY2023 | 63.7% | 19.0% | 15.4% |
| FY2024 | 63.9% | 16.3% | 13.2% |
| FY2025 | 64.0% | 19.5% | 12.9% |
Leverage and buybacks account for 6 points of the 14% return on equity in FY2025. The business earns 8% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$19.6B of goodwill — 54% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer. With goodwill over half the base, the ex-goodwill figure divides by a small remainder and moves sharply — read it as a direction, not a precise rate.
ROIC ex-goodwill is 24.12% against 11.02% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Converts 1.14x of reported profit into free cash flow over 5 years, with accruals negative.
Capex has been below depreciation for 7 consecutive years (0.46x on average over the last 5). Spending less than the asset base is consuming flatters free cash flow now and defers the cost — though depreciation also covers amortisation of acquired intangibles, which capex is not meant to replace.
Covers interest 5.9x even after a 30% EBITDA decline.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 8.40x |
| 5% | 7.98x |
| 10% | 7.56x |
| 15% | 7.14x |
| 20% | 6.72x |
| 25% | 6.30x |
| 30% | 5.88x |
| 35% | 5.46x |
| 40% | 5.04x |
| 45% | 4.62x |
| 50% | 4.20x |
| 55% | 3.78x |
| 60% | 3.36x |
Ladder as of 2025-12-31 (10-K); cash from the 2025-12-31 balance sheet; FCF from FY2025.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $291.86, free cash flow must compound 10.15%/yr for 10 years. It has done 18.56%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | 80.9% | 10.1% |
| FY2021 | −1.9% | 10.1% |
| FY2022 | −25.6% | 10.1% |
| FY2023 | 54.0% | 10.1% |
| FY2024 | 11.2% | 10.1% |
| FY2025 | 22.8% | 10.1% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
The implied rate has been matched or beaten in 4 of the last 6 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $3.25B | $3.25B |
| Share-based comp | $243M | $3.49B |
| Other non-cash & working capital | $1.55B | $5.04B |
| Operating cash flow | $5.04B | $5.04B |
| Capex | −$761M | $4.28B |
| Free cash flow | $4.28B | $4.28B |
| FCF after SBC | $4.04B | $4.04B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | -3.6% | -6.6% | -3.1 points |
| FY2021 | 19.2% | 11.9% | -7.3 points |
| FY2022 | 7.8% | 18.0% | 10.1 points |
| FY2023 | 11.1% | 5.6% | -5.5 points |
| FY2024 | 10.2% | 5.9% | -4.3 points |
| FY2025 | 11.2% | 1.3% | -9.9 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 70.9 days | 209.7 days | 47.5 days | 233.1 days |
| FY2020 | 68.7 days | 240.9 days | 55.8 days | 253.7 days |
| FY2021 | 64.5 days | 197 days | 67.1 days | 194.4 days |
| FY2022 | 70.5 days | 212.2 days | 75.1 days | 207.7 days |
| FY2023 | 67 days | 237.6 days | 74.4 days | 230.2 days |
| FY2024 | 64.4 days | 213.7 days | 75.1 days | 202.9 days |
| FY2025 | 58.7 days | 214.1 days | 72.5 days | 200.3 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -0.4 percent |
| FY2020 | -4.9 percent |
| FY2021 | -3.7 percent |
| FY2022 | -0.7 percent |
| FY2023 | -1.4 percent |
| FY2024 | -2.9 percent |
| FY2025 | -3.8 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 7 consecutive years to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-24 | Wells Preston Wendell VP, Chief Financial Officer | Other | 109 | $0.00 | $0 |
| 2026-09-22 | 2 co-filers VP, Chief Financial Officer | Other | 962 | $0.00 | $0 |
| 2026-08-21 | Crotty Dylan Bram Group President | Open-market saleindirect | 441 | $328.61 | $145k |
| 2026-08-19 | 20 co-filers Group filing | Open-market saleindirect | 40 | $331.81 | $13k |
| 2026-08-19 | 20 co-filers Group filing | Open-market saleindirect | 440 | $333.18 | $147k |
| 2026-08-19 | 20 co-filers Group filing | Open-market saleindirect | 200 | $333.93 | $67k |
| 2026-08-19 | 20 co-filers Group filing | Open-market saleindirect | 80 | $335.06 | $27k |
| 2026-08-19 | 20 co-filers Group filing | Open-market saleindirect | 320 | $336.79 | $108k |
| 2026-08-19 | 20 co-filers Group filing | Open-market saleindirect | 2,308 | $337.98 | $780k |
| 2026-08-19 | 20 co-filers Group filing | Open-market saleindirect | 11,257 | $338.90 | $3.8m |
| 2026-08-19 | 20 co-filers Group filing | Open-market saleindirect | 10,812 | $339.71 | $3.7m |
| 2026-08-19 | 20 co-filers Group filing | Open-market saleindirect | 16,612 | $340.71 | $5.7m |
| 2026-08-19 | 20 co-filers Group filing | Open-market saleindirect | 3,274 | $341.84 | $1.1m |
| 2026-08-19 | 20 co-filers Group filing | Open-market saleindirect | 3,852 | $342.80 | $1.3m |
| 2026-08-19 | 20 co-filers Group filing | Open-market saleindirect | 805 | $343.47 | $276k |
| 2026-08-18 | King Debra See Remarks | Open-market sale | 826 | $336.30 | $278k |
| 2026-08-18 | 20 co-filers Group filing | Open-market saleindirect | 2,239 | $331.74 | $743k |
| 2026-08-18 | 20 co-filers Group filing | Open-market saleindirect | 2,920 | $332.69 | $971k |
| 2026-08-18 | 20 co-filers Group filing | Open-market saleindirect | 8,404 | $333.82 | $2.8m |
| 2026-08-18 | 20 co-filers Group filing | Open-market saleindirect | 25,536 | $334.94 | $8.6m |
| 2026-08-18 | 20 co-filers Group filing | Open-market saleindirect | 131,752 | $335.64 | $44.2m |
| 2026-08-18 | 20 co-filers Group filing | Open-market saleindirect | 109,425 | $336.43 | $36.8m |
| 2026-08-18 | 20 co-filers Group filing | Open-market saleindirect | 16,243 | $337.63 | $5.5m |
| 2026-08-18 | 20 co-filers Group filing | Open-market saleindirect | 3,481 | $338.50 | $1.2m |
| 2026-08-01 | King Debra See Remarks | Tax withholding | 533 | $325.70 | $174k |
| 2026-08-01 | Fink M Kathryn VP, Chief HR Officer | Tax withholding | 111 | $325.70 | $36k |
| 2026-08-01 | Fletcher Robert S VP, Chief Legal Officer | Tax withholding | 94 | $325.70 | $31k |
| 2026-08-01 | Montagnino Kimberly Ann VP, Chief Comm. Officer | Tax withholding | 155 | $325.70 | $50k |
| 2026-07-17 | 2 co-filers VP, Chief Financial Officer | Other64d late | 1,777 | $0.00 | $0 |
| 2026-06-01 | Stiles Spencer S President and COO | Gift | 1,607 | $0.00 | $0 |
| 2026-05-28 | 6 co-filers VP, Chief Legal Officer | 10b5-1 plan sale | 120 | $304.23 | $37k |
| 2026-05-28 | 6 co-filers VP, Chief Legal Officer | 10b5-1 plan sale | 165 | $305.66 | $50k |
| 2026-05-28 | 6 co-filers VP, Chief Legal Officer | 10b5-1 plan sale | 2,809 | $306.56 | $861k |
| 2026-05-28 | 6 co-filers VP, Chief Legal Officer | 10b5-1 plan sale | 1,067 | $307.30 | $328k |
| 2026-05-28 | 6 co-filers VP, Chief Legal Officer | 10b5-1 plan sale | 258 | $308.79 | $80k |
| 2026-05-28 | 6 co-filers VP, Chief Legal Officer | 10b5-1 plan sale | 125 | $310.22 | $39k |
| 2026-05-26 | 6 co-filers Group filing | Open-market saleindirect | 21,807 | $310.77 | $6.8m |
| 2026-05-26 | 6 co-filers Group filing | Open-market saleindirect | 115,960 | $311.60 | $36.1m |
| 2026-05-26 | 6 co-filers Group filing | Open-market saleindirect | 114,059 | $312.44 | $35.6m |
| 2026-05-26 | 6 co-filers Group filing | Open-market saleindirect | 44,060 | $313.35 | $13.8m |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.